Delivery Order SPE2DB20D3101-SPE2DB24FRTU5

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,260.76, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of January 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,788.63, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,005.10 contract is for the supply of 4,568,093,505 units of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes treatment medication. The contract has a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a $2,081.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, to support federal healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract is valued at $3,671.01 and has a firm fixed price. The period of performance runs through September 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $1,303.15 and covers the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2024 and is a firm fixed price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,821.73, is for the procurement of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for healthcare purposes. The contract is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,272.07, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 28, 2025 and is not designated with a set-aside requirement, indicating open competition....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit organization. The $1,262.96 order is for NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The delivery order has a completion date of March 8, 2024 and was awarded on March 7, 2024. This order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a...
The U.S. Department of Defense (DoD) Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract, valued at $1,033.26, is for the provision of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. This delivery order contract falls under a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp, which has a potential value of...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRTU5
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $3,870.44, is for the supply of 4565668480 units of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between the DLA Troop Support Medical and AmerisourceBergen, which covers the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is set to be completed by September 4, 2024.

Generated 12/3/24, 9:55 AM